메뉴 건너뛰기




Volumn 16, Issue 4 A, 1996, Pages 1775-1780

Cell activation and death (apoptosis) induced by IL-2: Ultrastructural evidence

Author keywords

Apoptosis; IL 2; Immunotherapy; Ultrastructure

Indexed keywords

RECOMBINANT INTERLEUKIN 2;

EID: 0029783248     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (8)

References (16)
  • 1
    • 0024166189 scopus 로고
    • Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma: A preliminary report
    • Rosenberg SA, Packard BS, Aebersold PM: Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma: a preliminary report. New England J Med 25: 319-323, 1988.
    • (1988) New England J Med , vol.25 , pp. 319-323
    • Rosenberg, S.A.1    Packard, B.S.2    Aebersold, P.M.3
  • 2
    • 0025330178 scopus 로고
    • Home therapy with recombinant interleukin-2 and interferon-alpha 2b in advanced human malignancies
    • Atzpodien J, Korfer A, Franks CR, Poliwoda H, Kirchner H: Home therapy with recombinant interleukin-2 and interferon-alpha 2b in advanced human malignancies. Lancet 335: 1509-1512, 1990.
    • (1990) Lancet , vol.335 , pp. 1509-1512
    • Atzpodien, J.1    Korfer, A.2    Franks, C.R.3    Poliwoda, H.4    Kirchner, H.5
  • 3
    • 0025194233 scopus 로고
    • Immune responses in humans while receiving adoptive immunotherapy with recombinant interleukin-2 and lymphokine-activated killer cells: Acute anergy to mitogens and recall antigens
    • Ades E W, Bosse D, Orr S, Gillespie T: Immune responses in humans while receiving adoptive immunotherapy with recombinant interleukin-2 and lymphokine-activated killer cells: acute anergy to mitogens and recall antigens. Pathobiol 58: 78-83, 1990.
    • (1990) Pathobiol , vol.58 , pp. 78-83
    • Ades, E.W.1    Bosse, D.2    Orr, S.3    Gillespie, T.4
  • 4
    • 0025633477 scopus 로고
    • Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients. I. Phenotypic and functional analysis of the peripheral blood mononuclear cells
    • Fortis C, Ferrero E, Besana C, Biffi M, Heltai S, Galli L, Borri A, Schoenheit A, Rugarli C: Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients. I. Phenotypic and functional analysis of the peripheral blood mononuclear cells. Cancer Immunol Immunother 32: 161-166, 1990.
    • (1990) Cancer Immunol Immunother , vol.32 , pp. 161-166
    • Fortis, C.1    Ferrero, E.2    Besana, C.3    Biffi, M.4    Heltai, S.5    Galli, L.6    Borri, A.7    Schoenheit, A.8    Rugarli, C.9
  • 6
    • 0024264288 scopus 로고
    • Acute immunologic effects of interleukin-2 therapy in cancer patients: Decreased delayed -type hypersensitivity response and decreased proliferative response to soluble antigens
    • Wiebke EA, Rosenberg SA, Lotze MT,: Acute immunologic effects of interleukin-2 therapy in cancer patients: decreased delayed -type hypersensitivity response and decreased proliferative response to soluble antigens. J Clin Oncol 6: 1440-1449, 1988.
    • (1988) J Clin Oncol , vol.6 , pp. 1440-1449
    • Wiebke, E.A.1    Rosenberg, S.A.2    Lotze, M.T.3
  • 7
    • 85069081545 scopus 로고
    • Research of the optimal dose of interleukin-2 for the selective growth in vitro of lymphocytes with anti-tumoral cytolitic activity
    • Capelli E, Nano R, Asti M, Lavezzi L, Rossi A, Cuccia M, Salvucci O. Gerzeli G: Research of the optimal dose of interleukin-2 for the selective growth in vitro of lymphocytes with anti-tumoral cytolitic activity. Europ J Histochem 375: 18, 1993.
    • (1993) Europ J Histochem , vol.375 , pp. 18
    • Capelli, E.1    Nano, R.2    Asti, M.3    Lavezzi, L.4    Rossi, A.5    Cuccia, M.6    Salvucci, O.7    Gerzeli, G.8
  • 8
    • 0030324738 scopus 로고    scopus 로고
    • Morphological changes of lymphocytes activated with interleukin-2
    • Nano R, Barni S, Capelli E : Morphological changes of lymphocytes activated with interleukin-2. Haematologica 81: 93-94, 1996.
    • (1996) Haematologica , vol.81 , pp. 93-94
    • Nano, R.1    Barni, S.2    Capelli, E.3
  • 9
    • 0026017971 scopus 로고
    • Interleukin-2 programs mouse ab T lymphocytes for apoptosis
    • Lenardo MJ: Interleukin-2 programs mouse ab T lymphocytes for apoptosis. Nature 353: 858-861, 1991.
    • (1991) Nature , vol.353 , pp. 858-861
    • Lenardo, M.J.1
  • 14
    • 0025965167 scopus 로고
    • Receptor-stimulated death pathway is opened by antigen in mature T cells
    • Russel JH, White CL, Loh DY, Meleedy-Rey P: Receptor-stimulated death pathway is opened by antigen in mature T cells. Proc Natl Acad Sci USA 88: 2151-2155, 1991.
    • (1991) Proc Natl Acad Sci USA , vol.88 , pp. 2151-2155
    • Russel, J.H.1    White, C.L.2    Loh, D.Y.3    Meleedy-Rey, P.4
  • 15
    • 0027315279 scopus 로고
    • Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells
    • Wesselborg S, Janssen O, Kabelitz DJ: Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J Immunol 150: 4388-4345, 1993.
    • (1993) J Immunol , vol.150 , pp. 4388-14345
    • Wesselborg, S.1    Janssen, O.2    Kabelitz, D.J.3
  • 16
    • 0026672306 scopus 로고
    • Activation-driven cell death II. Quantitative differences alone distinguish stimuli triggering non transformed T cell proliferation or death
    • Ucker D, Meyers J, Obermiller PS: Activation-driven cell death II. Quantitative differences alone distinguish stimuli triggering non transformed T cell proliferation or death. J Immunol 149: 1583-1592. 1992.
    • (1992) J Immunol , vol.149 , pp. 1583-1592
    • Ucker, D.1    Meyers, J.2    Obermiller, P.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.